1887

Journal of General Virology header logo

Volume 104, Issue 10

Human immunodeficiency virus 1 5′-leader mutations in plasma viruses before and after the development of reverse transcriptase inhibitor-resistance mutations Open Access

Abstract

Human immunodeficiency virus 1 (HIV-1) reverse transcriptase (RT) initiation depends on interaction between viral 5′-leader RNA, RT and host tRNA3. Therefore, we sought to identify co-evolutionary changes between the 5′-leader and RT in viruses developing RT-inhibitor resistance mutations. We sequenced 5′-leader positions 37–356 of paired plasma virus samples from 29 individuals developing the nucleoside RT inhibitor (NRTI)-resistance mutation M184V, 19 developing a non-nucleoside RT inhibitor (NNRTI)-resistance mutation and 32 untreated controls. 5′-Leader variants were defined as positions where ≥20 % of next-generation sequencing (NGS) reads differed from the HXB2 sequence. Emergent mutations were defined as nucleotides undergoing a ≥4-fold change in proportion between baseline and follow-up. Mixtures were defined as positions containing ≥2 nucleotides each present in ≥20 % of NGS reads. Among 80 baseline sequences, 87 positions (27.2 %) contained a variant; 52 contained a mixture. Position 201 was the only position more likely to develop a mutation in the M184V (9/29 vs 0/32; =0.0006) or NNRTI-resistance (4/19 vs 0/32; =0.02; Fisher’s exact test) groups than the control group. Mixtures at positions 200 and 201 occurred in 45.0 and 28.8 %, respectively, of baseline samples. Because of the high proportion of mixtures at these positions, we analysed 5′-leader mixture frequencies in two additional datasets: five publications reporting 294 dideoxyterminator clonal GenBank sequences from 42 individuals and six National Center for Biotechnology Information (NCBI) BioProjects reporting NGS datasets from 295 individuals. These analyses demonstrated position 200 and 201 mixtures at proportions similar to those in our samples and at frequencies several times higher than at all other 5′-leader positions. Although we did not convincingly document co-evolutionary changes between RT and 5′-leader sequences, we identified a novel phenomenon, wherein positions 200 and 201 immediately downstream of the HIV-1 primer binding site exhibited an extraordinarily high likelihood of containing a nucleotide mixture. Possible explanations for the high mixture rates are that these positions are particularly error-prone or provide a viral fitness advantage.

  • Received:
  • Accepted:
  • Published Online:
© 2023 The Authors
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution.
Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.001898
2023-10-06
2024-05-08
Loading full text...

Full text loading...

/deliver/fulltext/jgv/104/10/jgv001898.html?itemId=/content/journal/jgv/10.1099/jgv.0.001898&mimeType=html&fmt=ahah

References

  1. Berkhout B. Structure and function of the human immunodeficiency virus leader RNA. In Cohn WE, Moldave K. eds Progress in Nucleic Acid Research and Molecular Biology vol 54 Cambridge, MA: Academic Press; 1996 pp 1–34
     [Google Scholar]
  2. Abbink TEM, Berkhout B. A novel long distance base-pairing interaction in human immunodeficiency virus type 1 RNA occludes the Gag start codon. J Biol Chem 2003; 278:11601–11611 [View Article] [PubMed]
     [Google Scholar]
  3. Song R, Kafaie J, Laughrea M. Role of the 5’ TAR stem–loop and the U5-AUG duplex in dimerization of HIV-1 genomic RNA. Biochemistry 2008; 47:3283–3293 [View Article] [PubMed]
     [Google Scholar]
  4. Isel C, Ehresmann C, Marquet R. Initiation of HIV reverse transcription. Viruses 2010; 2:213–243 [View Article] [PubMed]
     [Google Scholar]
  5. van Bel N, Ghabri A, Das AT, Berkhout B. The HIV-1 leader RNA is exquisitely sensitive to structural changes. Virology 2015; 483:236–252 [View Article] [PubMed]
     [Google Scholar]
  6. Tomezsko PJ, Corbin VDA, Gupta P, Swaminathan H, Glasgow M et al. Determination of RNA structural diversity and its role in HIV-1 RNA splicing. Nature 2020; 588:438–442 [View Article] [PubMed]
     [Google Scholar]
  7. Ye L, Gribling-Burrer A-S, Bohn P, Kibe A, Börtlein C et al. Short- and long-range interactions in the HIV-1 5’ UTR regulate genome dimerization and packaging. Nat Struct Mol Biol 2022; 29:306–319 [View Article] [PubMed]
     [Google Scholar]
  8. Keane SC, Summers MF. NMR studies of the structure and function of the HIV-1 5’-leader. Viruses 2016; 8:338 [View Article] [PubMed]
     [Google Scholar]
  9. Larsen KP, Mathiharan YK, Kappel K, Coey AT, Chen D-H et al. Architecture of an HIV-1 reverse transcriptase initiation complex. Nature 2018; 557:118–122 [View Article] [PubMed]
     [Google Scholar]
  10. Ha B, Larsen KP, Zhang J, Fu Z, Montabana E et al. High-resolution view of HIV-1 reverse transcriptase initiation complexes and inhibition by NNRTI drugs. Nat Commun 2021; 12:2500 [View Article] [PubMed]
     [Google Scholar]
  11. Dutilleul A, Rodari A, Van Lint C. Depicting HIV-1 transcriptional mechanisms: a summary of what we know. Viruses 2020; 12:1385 [View Article] [PubMed]
     [Google Scholar]
  12. Emery A, Swanstrom R. HIV-1: to splice or not to splice, that is the question. Viruses 2021; 13:181 [View Article] [PubMed]
     [Google Scholar]
  13. Lu K, Heng X, Summers MF. Structural determinants and mechanism of HIV-1 genome packaging. J Mol Biol 2011; 410:609–633 [View Article] [PubMed]
     [Google Scholar]
  14. Mailler E, Bernacchi S, Marquet R, Paillart J-C, Vivet-Boudou V et al. The life-cycle of the HIV-1 Gag-RNA complex. Viruses 2016; 8:248 [View Article] [PubMed]
     [Google Scholar]
  15. Krupkin M, Jackson LN, Ha B, Puglisi EV. Advances in understanding the initiation of HIV-1 reverse transcription. Curr Opin Struct Biol 2020; 65:175–183 [View Article] [PubMed]
     [Google Scholar]
  16. Chen S, Zhou Y, Chen Y, Gu J. Fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 2018; 34:i884–i890 [View Article] [PubMed]
     [Google Scholar]
  17. Li H, Birol I. Minimap2: pairwise alignment for nucleotide sequences. Bioinformatics 2018; 34:3094–3100 [View Article]
     [Google Scholar]
  18. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 2009; 25:2078–2079 [View Article]
     [Google Scholar]
  19. Rice P, Longden I, Bleasby A. EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet 2000; 16:276–277 [View Article] [PubMed]
     [Google Scholar]
  20. Katoh K, Frith MC. Adding unaligned sequences into an existing alignment using MAFFT and LAST. Bioinformatics 2012; 28:3144–3146 [View Article] [PubMed]
     [Google Scholar]
  21. Novitsky VA, Montano MA, McLane MF, Renjifo B, Vannberg F et al. Molecular cloning and phylogenetic analysis of human immunodeficiency virus type 1 subtype C: a set of 23 full-length clones from Botswana. J Virol 1999; 73:4427–4432 [View Article] [PubMed]
     [Google Scholar]
  22. Rolland M, Tovanabutra S, deCamp AC, Frahm N, Gilbert PB et al. Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial. Nat Med 2011; 17:366–371 [View Article] [PubMed]
     [Google Scholar]
  23. Ochsenbauer C, Edmonds TG, Ding H, Keele BF, Decker J et al. Generation of transmitted/founder HIV-1 infectious molecular clones and characterization of their replication capacity in CD4 T lymphocytes and monocyte-derived macrophages. J Virol 2012; 86:2715–2728 [View Article] [PubMed]
     [Google Scholar]
  24. Parrish NF, Gao F, Li H, Giorgi EE, Barbian HJ et al. Phenotypic properties of transmitted founder HIV-1. Proc Natl Acad Sci USA 2013; 110:6626–6633 [View Article] [PubMed]
     [Google Scholar]
  25. Gondim MVP, Sherrill-Mix S, Bibollet-Ruche F, Russell RM, Trimboli S et al. Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption. Sci Transl Med 2021; 13:eabd8179 [View Article] [PubMed]
     [Google Scholar]
  26. Gall A, Ferns B, Morris C, Watson S, Cotten M et al. Universal amplification, next-generation sequencing, and assembly of HIV-1 genomes. J Clin Microbiol 2012; 50:3838–3844 [View Article] [PubMed]
     [Google Scholar]
  27. Illingworth CJR, Roy S, Beale MA, Tutill H, Williams R et al. On the effective depth of viral sequence data. Virus Evol 2017; 3:vex030 [View Article] [PubMed]
     [Google Scholar]
  28. Fedonin GG, Fantin YS, Favorov AV, Shipulin GA, Neverov AD. VirGenA: a reference-based assembler for variable viral genomes. Brief Bioinform 2019; 20:15–25 [View Article] [PubMed]
     [Google Scholar]
  29. Vilsker M, Moosa Y, Nooij S, Fonseca V, Ghysens Y et al. Genome detective: an automated system for virus identification from high-throughput sequencing data. Bioinformatics 2019; 35:871–873 [View Article] [PubMed]
     [Google Scholar]
  30. Zhang Y, Wymant C, Laeyendecker O, Grabowski MK, Hall M et al. Evaluation of phylogenetic methods for inferring the direction of human immunodeficiency virus (HIV) transmission: HIV Prevention Trials Network (HPTN) 052. Clin Infect Dis 2021; 72:30–37 [View Article] [PubMed]
     [Google Scholar]
  31. Yamaguchi J, Olivo A, Laeyendecker O, Forberg K, Ndembi N et al. Universal Target Capture of HIV Sequences From NGS Libraries. Front Microbiol 2018; 9:2150 [View Article] [PubMed]
     [Google Scholar]
  32. Kouyos RD, von Wyl V, Yerly S, Böni J, Rieder P et al. Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection. Clin Infect Dis 2011; 52:532–539 [View Article] [PubMed]
     [Google Scholar]
  33. Andersson E, Shao W, Bontell I, Cham F, Cuong DD et al. Evaluation of sequence ambiguities of the HIV-1 pol gene as a method to identify recent HIV-1 infection in transmitted drug resistance surveys. Infect Genet Evol 2013; 18:125–131 [View Article] [PubMed]
     [Google Scholar]
  34. Bruner KM, Murray AJ, Pollack RA, Soliman MG, Laskey SB et al. Defective proviruses rapidly accumulate during acute HIV-1 infection. Nat Med 2016; 22:1043–1049 [View Article] [PubMed]
     [Google Scholar]
  35. Das AT, Vink M, Berkhout B. Alternative tRNA priming of human immunodeficiency virus type 1 reverse transcription explains sequence variation in the primer-binding site that has been attributed to APOBEC3G activity. J Virol 2005; 79:3179–3181 [View Article] [PubMed]
     [Google Scholar]
  36. Huthoff H, Berkhout B. Mutations in the TAR hairpin affect the equilibrium between alternative conformations of the HIV-1 leader RNA. Nucleic Acids Res 2001; 29:2594–2600 [View Article] [PubMed]
     [Google Scholar]
  37. Vrolijk MM, Ooms M, Harwig A, Das AT, Berkhout B. Destabilization of the TAR hairpin affects the structure and function of the HIV-1 leader RNA. Nucleic Acids Res 2008; 36:4352–4363 [View Article] [PubMed]
     [Google Scholar]
  38. Ding P, Kharytonchyk S, Kuo N, Cannistraci E, Flores H et al. 5’-Cap sequestration is an essential determinant of HIV-1 genome packaging. Proc Natl Acad Sci USA 2021; 118:e2112475118 [View Article] [PubMed]
     [Google Scholar]
  39. Brown JD, Kharytonchyk S, Chaudry I, Iyer AS, Carter H et al. Structural basis for transcriptional start site control of HIV-1 RNA fate. Science 2020; 368:413–417 [View Article] [PubMed]
     [Google Scholar]
  40. Oude Essink BB, Back NKT, Berkhout B. Increased polymerase fidelity of the 3TC-resistant variants of HIV-1 reverse transcriptase. Nucleic Acids Res 1997; 25:3212–3217 [View Article] [PubMed]
     [Google Scholar]
  41. Hsu M, Inouye P, Rezende L, Richard N, Li Z et al. Higher fidelity of RNA-dependent DNA mispair extension by M184V drug-resistant than wild-type reverse transcriptase of human immunodeficiency virus type 1. Nucleic Acids Res 1997; 25:4532–4536 [View Article] [PubMed]
     [Google Scholar]
  42. Jonckheere H, Witvrouw M, De Clercq E, Anné J. Lamivudine resistance of HIV type 1 does not delay development of resistance to nonnucleoside HIV type 1-specific reverse transcriptase inhibitors as compared with wild-type HIV type 1. AIDS Res Hum Retroviruses 1998; 14:249–253 [View Article] [PubMed]
     [Google Scholar]
  43. Keulen W, van Wijk A, Schuurman R, Berkhout B, Boucher CA. Increased polymerase fidelity of lamivudine-resistant HIV-1 variants does not limit their evolutionary potential. AIDS 1999; 13:1343–1349 [View Article] [PubMed]
     [Google Scholar]
  44. Stockdale AJ, Saunders MJ, Boyd MA, Bonnett LJ, Johnston V et al. Effectiveness of protease inhibitor/nucleos(t)ide reverse transcriptase inhibitor-based second-line antiretroviral therapy for the treatment of human immunodeficiency virus type 1 infection in Sub-Saharan Africa: a systematic review and meta-analysis. Clin Infect Dis 2018; 66:1846–1857 [View Article] [PubMed]
     [Google Scholar]
  45. Zhou S, Hill CS, Spielvogel E, Clark MU, Hudgens MG et al. Unique molecular identifiers and multiplexing amplicons maximize the utility of deep sequencing to critically assess population diversity in RNA viruses. ACS Infect Dis 2022; 8:2505–2514 [View Article] [PubMed]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.001898
Loading
Human immunodeficiency virus 1 5′-leader mutations in plasma viruses before and after the development of reverse transcriptase inhibitor-resistance mutations
J. Gen. Virol. 104, 001898 (2023); https://doi.org/10.1099/jgv.0.001898
/content/journal/jgv/10.1099/jgv.0.001898
/content/journal/jgv/10.1099/jgv.0.001898
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error